Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.

Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.

Item
http://www.wikidata.org/entity/Q36666594
Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic ReviewMedicare Part D and quality of prescription medication use in older adultsSocial, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected menHousing status and the health of people living with HIV/AIDSAssessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic reviewThe Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable PopulationsHomelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting.Medicare Part D's effect on the under- and overuse of medications: a systematic review.Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication.Navigating Barriers to Vocational Rehabilitation for HIV-Positive Persons.Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy.Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review.Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.
P2860

Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.

Item
http://www.wikidata.org/entity/Q36666594
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Implementation of the Medicare ...... roviral therapy interruptions.
@ast
Implementation of the Medicare ...... roviral therapy interruptions.
@en
type
label
Implementation of the Medicare ...... roviral therapy interruptions.
@ast
Implementation of the Medicare ...... roviral therapy interruptions.
@en
prefLabel
Implementation of the Medicare ...... roviral therapy interruptions.
@ast
Implementation of the Medicare ...... roviral therapy interruptions.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Implementation of the Medicare ...... roviral therapy interruptions.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932